A new study that may give hope to people suffering from borderline personality disorder (BPD) reveals that marijuana may alleviate some of the symptoms.
What is BPD? BPD, also known as Emotionally Unstable Personality Disorder (EUPD), is a mental health problem that causes a range of symptoms and can be grouped into four main areas: 1) Emotional lability, 2) Thinking or perceiving patterns. 3) impulsive behavior and 4) impairment of social functioning.
More than 14 million Americans are estimated to suffer from this disorder, according to McLean Hospital data. Unfortunately, while BDP is not a rare condition (more common than schizophrenia or bipolar disorder), there is no cure.
Cannabis can help, according to a case series published in the October issue of Brain Sciences.
The researchers first pointed out that previous literature pointed out that dysfunction of the endocannabinoid system, a key brain region responsible for emotional processing and stress response, could lead to the manifestation of some EUPD symptoms.
According to 2009 guidelines published by the National Institute for Health and Care Excellence (NICE), “no drug has established efficacy in the treatment or management of EUPD,” although patients are usually treated with antipsychotics, antidepressants, Medications and mood stabilizers are prescribed.
Fortunately, this case series of seven participants with EUPD who were treated with cannabis-based medications offers hope for the development of more efficient and safer natural remedies.
“Our results show that CBMP [cannabis-based medicinal products] Six participants reported marked improvement in symptoms and function, so it was effective and well-tolerated,” the researchers wrote. Further studies are needed to confirm the tolerability, efficacy and dosing strategy.”
major highlights
Most of the participants were young, with 5 out of 7 under the age of 30.
Participants were assessed initially and then again one month after being treated with cannabis-based products.
Symptom improvement was assessed by both participants and a psychiatrist.
Participants were prescribed marijuana products based on clinical evaluation. This takes into account patient preferences and individual choices regarding route of administration or desired clinical effect.
treatment is well tolerated Also, no participants reported adverse side effects.
“To our knowledge, this case series represents the first medical evidence for the use of CBMP in the clinical management of patients diagnosed with EUPD,” CBMP significantly improves symptoms associated with EUPD. Therefore, it justifies the need for further research on this therapeutic strategy. ”
Photo: Courtesy of Aditya Naidu via Unsplash